A 55-year-old presents with CAP and MRSA risk factors. Between linezolid and vancomycin, which choice can reduce toxin production and may improve outc...

Question

A 55-year-old presents with CAP and MRSA risk factors. Between linezolid and vancomycin, which choice can reduce toxin production and may improve outcomes in necrotising pneumonia?

Accepted Answer

Linezolid only

Answer

Vancomycin only

Answer

Either; no differences exist

Answer

Daptomycin IV

"mrsa pneumonia" MCQ (SBA): MRSA pneumonia

A 55-year-old presents with CAP and MRSA risk factors. Between linezolid and vancomycin, which choice can reduce toxin production and may improve outcomes in necrotising pneumonia?